W S Hillis

Author PubWeight™ 88.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Impact of a policy of direct admission to a coronary care unit on use of thrombolytic treatment. Br Heart J 1989 4.62
2 Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921. Br Heart J 1985 2.92
3 Cardiac troponin T. Lancet 1993 2.13
4 Hemodynamic and coronary effects of intravenous eletriptan, a 5HT1B/1D-receptor agonist. Clin Pharmacol Ther 1999 2.06
5 The genetic determination of left ventricular mass in healthy adults. Eur Heart J 2003 1.77
6 Electrocardiographic prediction of coronary artery patency after thrombolytic treatment in acute myocardial infarction: use of the ST segment as a non-invasive marker. Br Heart J 1988 1.75
7 Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J 1998 1.71
8 Humoral and cellular immune responses up to 7.5 years after administration of streptokinase for acute myocardial infarction. Eur Heart J 1999 1.64
9 Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators. Circulation 1997 1.47
10 Effects of nadolol on arrhythmias during laparoscopy performed under general anaesthesia. Br J Anaesth 1988 1.41
11 Assessment by general practitioners of suitability of thrombolysis in patients with suspected acute myocardial infarction. Br Heart J 1993 1.40
12 Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation. Circulation 1993 1.26
13 Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG. Br Heart J 1992 1.22
14 Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction. Lancet 1990 1.20
15 A prospective randomized trial of tocainide in patients following myocardial infarction. Am Heart J 1980 1.11
16 The use of BRL26921 (APSAC) as fibrinolytic therapy in acute myocardial infarction. Eur Heart J 1985 1.11
17 Relation between extent of coronary artery disease and severity of hyperlipoproteinaemia. Br Heart J 1975 1.10
18 Wide variation in the use of thrombolytic therapy among junior doctors in south and central Scotland. Health Bull (Edinb) 1996 1.09
19 Leucocyte ascorbic acid levels after acute myocardial infarction. Br Heart J 1972 1.08
20 Haemodynamic effects of prenalterol in patients with coronary heart disease. Br Heart J 1980 1.07
21 The effect of i.v. sumatriptan, a selective 5-HT1-receptor agonist on central haemodynamics and the coronary circulation. Br J Clin Pharmacol 1992 1.06
22 ABC of sports medicine. Sudden death in sport. BMJ 1994 0.99
23 Alcoholic ketoacidosis: a case report. Scott Med J 1987 0.99
24 Familial pattern of corticosteroids and their metabolism in adult human subjects--the Scottish Adult Twin Study. J Clin Endocrinol Metab 1999 0.98
25 Questionnaire survey of thrombolytic treatment in accident and emergency departments in the United Kingdom. BMJ 1998 0.97
26 Intracoronary thrombolytic therapy performed within a coronary care unit: one year's experience. Scott Med J 1986 0.96
27 Exercise prescription in adults with congenital heart disease: a long way to go. Heart 2000 0.96
28 The long-term management of the patient with an aortic coarctation repair. Eur Heart J 1998 0.94
29 Antiarrhythmic drugs. Br Med J (Clin Res Ed) 1983 0.94
30 Electrophysiological effects of felodipine. Drugs 1985 0.93
31 The ergoreflex in patients with chronic stable heart failure. Int J Cardiol 1999 0.93
32 Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rate. Am J Cardiol 1987 0.91
33 Fragmin in unstable angina pectoris or in non-Q-wave acute myocardial infarction (the FRIC study). Fragmin in Unstable Coronary Artery Disease. Am J Cardiol 1997 0.90
34 Outcomes of transposition of the great arteries in the ear of atrial inflow correction. Heart 1998 0.90
35 Cardiovascular effects of a new inotropic agent, U. K. 14275, in patients with coronary heart disease. Br J Clin Pharmacol 1977 0.88
36 The determination of carotid intima medial thickness in adults--a population-based twin study. Atherosclerosis 2003 0.87
37 The prevalence of left ventricular hypertrophy in elite professional footballers. Int J Cardiol 1999 0.87
38 Some aspects of the clinical pharmacology of intravenous disopyramide after myocardial infarction. J Int Med Res 1976 0.86
39 Failure of single dose amoxycillin as prophylaxis against endocarditis. Br Med J (Clin Res Ed) 1984 0.84
40 Increased titres of anti-human heat shock protein 60 predict an adverse one year prognosis in patients with acute cardiac chest pain. Heart 2005 0.84
41 CABG in the elderly: the Glasgow experience. Gerontology 1989 0.84
42 Epileptiform seizures and electroencephalographic abnormalities as manifestations of digoxin toxicity. Br Med J (Clin Res Ed) 1982 0.83
43 Pre-dosing antibody levels and efficacy of thrombolytic drugs containing streptokinase. Br Heart J 1994 0.83
44 Noninvasive assessment of the haemodynamic effects of nicardipine in normotensive subjects. Br J Clin Pharmacol 1985 0.82
45 Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure. Br J Clin Pharmacol 1994 0.82
46 The pharmacokinetics of R- and S-tocainide in patients with acute ventricular arrhythmias. Br J Clin Pharmacol 1986 0.82
47 An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects. Clin Endocrinol (Oxf) 2001 0.81
48 Systolic time intervals in thyroid disease. Clin Endocrinol (Oxf) 1975 0.81
49 A species difference in the presystemic metabolism of carbazeran in dog and man. Xenobiotica 1984 0.81
50 The acute haemodynamic effects of intravenous enalaprilic acid (MK422) in patients with left ventricular dysfunction. Br J Clin Pharmacol 1987 0.81
51 Walk or run? Is high-intensity exercise more effective than moderate-intensity exercise at reducing cardiovascular risk? Scott Med J 2011 0.81
52 Cardiac standstill due to digoxin poisoning successfully treated with atrial pacing. Br Med J 1973 0.80
53 A dose-ranging study of UK-68,798, a novel class III anti-arrhythmic agent, in normal volunteers. Br J Clin Pharmacol 1991 0.80
54 Family planning requirements of adults with congenital heart disease. Heart 1997 0.80
55 Effect of exercise in hypertension controlled with metoprolol or methyldopa. Clin Sci (Lond) 1979 0.79
56 Reactive hyperemia: an index of the significance of coronary stenoses. Am Heart J 1976 0.79
57 Phosphodiesterase inhibitors: haemodynamic effects related to the treatment of cardiac failure. Eur Heart J 1982 0.79
58 Anti-heat shock protein 65 titres in acute myocardial infarction. Lancet 1994 0.79
59 The effects of a new beta-adrenoceptor blocking compound, tolamolol, on haemo-dynamics and myocardial function in man. Br J Pharmacol 1974 0.79
60 Electrophysiological effects of felodipine in combination with metoprolol. Drugs 1985 0.79
61 Screening for hypertrophic cardiomyopathy. BMJ 1993 0.78
62 Athletic left ventricular hypertrophy: long-term studies are required. Eur Heart J 2000 0.78
63 Haemodynamic effects of BM 10.188, a new orally active inotropic agent, in healthy volunteers. Br J Clin Pharmacol 1982 0.78
64 Reduced heart rate variability following repair of tetralogy of Fallot. Heart 1999 0.78
65 Effects of exercise position on the ventilatory responses to exercise in chronic heart failure. Int J Cardiol 1998 0.78
66 Electrocardiographic evidence of myocardial salvage after thrombolysis in acute myocardial infarction. Br Heart J 1989 0.78
67 Ventilatory response to erect and supine exercise. Med Sci Sports Exerc 1999 0.78
68 Antimycobacterial hsp65 and rheumatoid factor titres in a population of normal twins: evidence of genetic control of rheumatoid factor. Clin Exp Immunol 1995 0.77
69 Transpulmonary pharmacokinetics of an ACE inhibitor (perindoprilat) in man. Br J Clin Pharmacol 1991 0.77
70 Management strategies in unstable coronary artery disease--current problems and future directions. The UCAD Council. Clin Cardiol 1999 0.77
71 A pilot study of the efficacy and safety of bolus administration of alteplase in acute myocardial infarction. Br Heart J 1991 0.77
72 The effects of acute dynamic exercise on haemostasis in fi rst class Scottish football referees. Br J Sports Med 2010 0.77
73 Responses to constant work exercise in patients with chronic heart failure. Heart 1999 0.76
74 Sumatriptan reduces exercise capacity in healthy males: a peripheral effect of 5-hydroxytryptamine agonism? Clin Sci (Lond) 2000 0.76
75 Sumatriptan and chest pain. Lancet 1993 0.76
76 Changes in lignocaine disposition during long-term infusion in patients with acute ventricular arrhythmias. Ther Drug Monit 1987 0.76
77 Glucocorticoids contribute to the heritability of leptin in Scottish adult female twins. Clin Endocrinol (Oxf) 2004 0.76
78 Effects of subcutaneous naratriptan on systemic and pulmonary haemodynamics and coronary artery diameter in humans. J Cardiovasc Pharmacol 1999 0.76
79 Sumatriptan-induced chest pain. Lancet 1994 0.75
80 Haemodynamics and myocardial function after sotalol. Br Heart J 1972 0.75
81 The haemodynamic effect of the 5HT1 agonist BMS-180048: a class effect of triptans? Br J Clin Pharmacol 1999 0.75
82 Changes in systolic time intervals-a non-invasive marker for the haemodynamic effects of sumatriptan. Br J Clin Pharmacol 1999 0.75
83 Effect of afterload reduction in patients with ventricular and physiological pacing. Br Heart J 1984 0.75
84 Vasculitis complicating treatment with intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Br Heart J 1988 0.75
85 Management of polycythaemia in adults with cyanotic congenital heart disease. Heart 1999 0.75
86 Role of the general practitioner in managing patients with myocardial infarction. BMJ 1989 0.75
87 The effect of glyceryl trinitrate ointment on heart rate--corrected systolic time intervals in angina pectoris. Br J Clin Pharmacol 1982 0.75
88 Early cardiovascular changes with ibopamine: evidence for a biphasic haemodynamic action. Br J Clin Pharmacol 1987 0.75
89 Exercise testing, symptoms, and clinical outcome in aortic stenosis. Heart 2000 0.75
90 Reactive hyperemia as an index to coronary arterial narrowing. Trans Am Clin Climatol Assoc 1975 0.75
91 Endocarditis in intravenous drug abusers with staphylococcal septicaemia. Br Heart J 1989 0.75
92 The effects of propranolol and acebutolol on left ventricular function and coronary haemodynamics in the conscious dog with myocardial ischaemia. Br J Pharmacol 1980 0.75
93 Clinical significance of cerebral emboli signals. Lancet 1993 0.75
94 Comparative study of the effects of penbutolol and propranolol in the treatment of angina pectoris. Arzneimittelforschung 1980 0.75
95 Anti-anginal efficacy of intravenous amlodipine assessed by means of atrial pacing. Postgrad Med J 1991 0.75
96 Effect of ketanserin on central haemodynamics and coronary circulation. J Cardiovasc Pharmacol 1998 0.75
97 Long-term amiodarone therapy raises serum cholesterol. Eur J Clin Pharmacol 1991 0.75
98 Kinetic predictive techniques applied to lignocaine therapeutic drug monitoring. Ther Drug Monit 1983 0.75
99 The incidence and mechanism of hypotension following thrombolytic therapy for acute myocardial infarction with streptokinase-containing agents--lack of relationship to pretreatment streptokinase resistance. Eur Heart J 1993 0.75
100 Significance of severity of coronary arterial stenosis: metabolic studies and correlation with hyperemic response. J Surg Res 1975 0.75
101 Modern management of heart failure. Br J Hosp Med 1986 0.75
102 Angiomatous arteriovenous fistula between aorta, great cardiac vein and pulmonary artery. An incidental finding during mitral valvotomy. J Cardiovasc Surg (Torino) 1978 0.75
103 Non-invasive cardiovascular assessment of indapamide in patients with essential hypertension. Postgrad Med J 1981 0.75
104 Antagonism by INPEA of isoprenaline-induced tachycardia in man. J Pharm Pharmacol 1972 0.75
105 The value of exercise. Practitioner 2001 0.75
106 Clinical applications of sodium nitroprusside. Scott Med J 1980 0.75
107 Left ventricular aneurysm complicating acute myocardial infarction occurring during pregnancy. Case report. Br J Obstet Gynaecol 1983 0.75
108 Comparative efficacy of Univer and conventional verapamil in the control of ventricular response in atrial fibrillation. Br J Clin Pract Suppl 1988 0.75
109 Amiodarone therapy and glucose tolerance--a prospective trial. Eur J Clin Pharmacol 1988 0.75
110 Long-term comparison of metoprolol and methyldopa in the treatment of hypertension. Clin Cardiol 1980 0.75
111 The haematological management of patients with cyanotic congenital heart disease. A time for consensus? Eur Heart J 1997 0.75
112 Thrombolytic therapy in acute myocardial infarction in the elderly. Gerontology 1987 0.75
113 Captopril/metolazone induced renal failure. Lancet 1986 0.75
114 Pharmacodynamics of amlodipine: hemodynamic effects and antianginal efficacy after atrial pacing. Am Heart J 1989 0.75